Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
September 30, 2026 -6.062M
June 30, 2026 -20.92M
March 31, 2026 -19.44M
December 31, 2025 -18.08M
September 30, 2025 -19.63M
June 30, 2025 -5.926M
March 31, 2025 -35.14M
December 31, 2024 -0.4598M
September 30, 2024 -23.83M
June 30, 2024 -29.85M
March 31, 2024 -5.557M
December 31, 2023 -0.5447M
September 30, 2023 -31.62M
June 30, 2023 50.57M
March 31, 2023 -35.87M
December 31, 2022 155.17M
September 30, 2022 -40.45M
June 30, 2022 -34.88M
March 31, 2022 -49.04M
December 31, 2021 -45.14M
September 30, 2021 -17.13M
June 30, 2021 -33.07M
March 31, 2021 -42.95M
December 31, 2020 -7.393M
September 30, 2020 -16.53M
Date Value
June 30, 2020 -8.457M
March 31, 2020 -11.86M
December 31, 2019 -7.691M
September 30, 2019 -2.838M
June 30, 2019 9.366M
March 31, 2019 -5.411M
December 31, 2018 -5.482M
September 30, 2018 -6.599M
June 30, 2018 -7.709M
March 31, 2018 -0.361M
December 31, 2017 10.11M
September 30, 2017 -1.403M
June 30, 2017 -4.211M
March 31, 2017 -4.964M
December 31, 2016 -3.90M
September 30, 2016 -6.734M
June 30, 2016 -4.207M
March 31, 2016 -4.437M
December 31, 2015 -4.156M
September 30, 2015 -5.458M
June 30, 2015 -3.975M
March 31, 2015 -4.595M
December 31, 2014 -6.020M
September 30, 2014 -9.298M
June 30, 2014 -5.518M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 11.50M
Emergent BioSolutions, Inc. 100.10M
Ionis Pharmaceuticals, Inc. -179.42M
United Therapeutics Corp. 306.50M
Ocugen, Inc. -15.74M